Skip to content

Clinical trials

End Stage Liver Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: End Stage Liver Disease Country / region: Canada Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20131
20152
20171
20191
20211
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status2
Active, not recruiting1
Terminated1
Withdrawn1
Suspended1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre hospitalier de l'Université de Montréal (CHUM)4
Arbor Research Collaborative for Health2
University of Alberta2
Axcella Health, Inc1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
End Stage Liver Disease12
Liver Diseases5
Fibrosis2
Liver Cirrhosis2
Cholestasis1
Fatty Liver1
Hepatic Encephalopathy1
Hepatitis C1
Hypertension, Portal1
Liver Failure, Acute1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.